Published 19:37 IST, August 12th 2020
Philippines to meet Russian state research facility experts to discuss vaccine's trials
Phillippines Health Undersecretary Vergeire said that the teams would hold a discussion on clinical trials and research that went into the development.
Advertisement
On August 12, Philippine scientists prepared to meet with representatives of Russian state research facility, Gamaleya, to secure "complete dossier" on Russia’s coronavirus vaccine. Health Undersecretary Rosario Vergeire said in a statement that teams would hold a discussion on clinical trials and research that went into development of COVID-19 vaccine "Sputnik V". Furr, she stated that it would be me clear if international concerns about “t eugh scientific evidence” about Russia’s vaccine holds true, reports confirmed.
President of Phillippines, Rodrigo Duterte, lauded Russia for being world’s first country to have found vaccine against malignant coronavirus. Furr, he offered to be "injected in public" to alleviate any fears of side-effects, according to reports. Named after Soviet Union's launch of world’s first satellite, vaccine is scheduled to launch on August 12. Having plans to conduct its own clinical trials of anti-flu drug Avigan for over nine months, and to upsurge of cases in recent past, Phillippines has h high expectations of vaccine to be invented. According to several reports, country h earlier urged China to have it participate as island nation h highest cases in Asia.
Advertisement
Advertisement
'Vaccine safe and tested'
Earlier on August 6, Russian Defence Ministry, Deputy Health Minister Oleg Gridnev reportedly anunced that country will launch world’s first clinically approved vaccine against vel coronavirus manufactured by Gamaleya Research Institute in collaboration with Russian Defence Ministry. Moscow declared itself front-runner in search for a potential vaccine, claiming, that it began experimental COVID-19 shots less than two months ago and its vaccine was safe and “tested”, as per reports. He of Russia's Direct Investment Fund, who initiated effort, reportedly said that a vaccine developed by Gamaleya research institute completed phase III study. It’s final sts involved tens of thousands of people, he ded. experimental vaccine is safe and really works, he was reported as saying by a news ncy.
Advertisement
19:37 IST, August 12th 2020